Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut)-Reference-Cited by-同舟云学术

Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut)

Published:2019-06-27 Issue:1 Volume:14 Page:
ISSN:1750-1172
Container-title:Orphanet Journal of Rare Diseases
language:en
Short-container-title:Orphanet J Rare Dis

Author:

Guarga Laura,Badia Xavier,Obach Mercè,Fontanet Manel,Prat Alba,Vallano Atonio,Torrent Josep,Pontes Caridad^ORCID

Funder

CatSalut

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics(clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13023-019-1121-6.pdf

Reference14 articles.

1. Ministerio de Sanidad Servicios Sociales e Igualdad . [cited 2017 May 1] Available from: National Health System. Spain. https://www.msssi.gob.es/organizacion/ministerio/home.htm .

2. Generalitat de Catalunya. Pla de Salut de Catalunya 2016-2020. [cited 2017 May 1] Available from: http://salutweb.gencat.cat/ca/el_departament/Pla_salut/pla-de-salut-2016-2020/ .

3. Agencia de Evaluación de Tecnologías Sanitarias (AETS). Instituto de Salud Carlos III - Ministerio de Economía y Competitividad. Criterios de financiación y reembolso de los medicamentos huérfanos. 2016.

4. Goetghebeur M, Castro-Jaramillo H, Baltussen R, et al. The art of medicine the art of priority setting. Lancet. 2017;389:17.

5. Goetghebeur MM, Wagner M, Khoury H, Levitt RJ, Erickson LJ, Rindress D. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal. Med Decis Mak. 2012;32(2):376–88.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Societal Preferences in Health Technology Assessments for Rare Diseases and Orphan Drugs: A Systematic Literature Review of New Analytic Approaches;Value in Health Regional Issues;2024-11

2. The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD);Orphanet Journal of Rare Diseases;2024-08-23

3. A novel MCGDM technique based on correlation coefficients under probabilistic hesitant fuzzy environment and its application in clinical comprehensive evaluation of orphan drugs;PLOS ONE;2024-05-06

4. A Step Toward the Development of the First National Multi-Criteria Decision Analysis Framework to Support Healthcare Decision Making in Saudi Arabia;Value in Health Regional Issues;2024-05

5. The application of multi-criteria decision analysis in evaluating the value of drug-oriented intervention: a literature review;Frontiers in Pharmacology;2024-04-24